vs
和黄医药（HCM）与Priority Technology Holdings, Inc.（PRTH）财务数据对比。点击上方公司名可切换其他公司
和黄医药的季度营收约是Priority Technology Holdings, Inc.的1.1倍（$270.8M vs $247.1M），Priority Technology Holdings, Inc.净利率更高（3.6% vs 0.7%，领先2.9%），Priority Technology Holdings, Inc.同比增速更快（8.8% vs -16.5%），Priority Technology Holdings, Inc.自由现金流更多（$30.9M vs $3.4M）
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
Priority Technology Holdings, Inc.是一家聚焦信息技术领域的企业，业务围绕计算机、通信系统等相关信息设备展开，涵盖信息的创建、处理、存储、检索与传输等相关信息技术应用服务，依托计算机科学与工程技术支撑业务开展。
HCM vs PRTH — 直观对比
营收规模更大
HCM
是对方的1.1倍
$247.1M
营收增速更快
PRTH
高出25.4%
-16.5%
净利率更高
PRTH
高出2.9%
0.7%
自由现金流更多
PRTH
多$27.5M
$3.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.8M | $247.1M |
| 净利润 | $2.0M | $8.9M |
| 毛利率 | 37.7% | — |
| 营业利润率 | -13.2% | 13.6% |
| 净利率 | 0.7% | 3.6% |
| 营收同比 | -16.5% | 8.8% |
| 净利润同比 | -83.6% | 23.9% |
| 每股收益（稀释后） | $0.00 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCMPRTH
| Q4 25 | $270.8M | $247.1M | ||
| Q3 25 | — | $241.4M | ||
| Q2 25 | $277.7M | $239.8M | ||
| Q1 25 | $324.5M | $224.6M | ||
| Q4 24 | — | $227.1M | ||
| Q3 24 | — | $227.0M | ||
| Q2 24 | $305.7M | $219.9M | ||
| Q1 24 | — | $205.7M |
净利润HCMPRTH
| Q4 25 | $2.0M | $8.9M | ||
| Q3 25 | — | $27.6M | ||
| Q2 25 | $455.0M | $10.9M | ||
| Q1 25 | $11.9M | $8.3M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | — | $10.6M | ||
| Q2 24 | $25.8M | $994.0K | ||
| Q1 24 | — | $5.2M |
毛利率HCMPRTH
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
营业利润率HCMPRTH
| Q4 25 | -13.2% | 13.6% | ||
| Q3 25 | — | 15.6% | ||
| Q2 25 | -1.3% | 15.6% | ||
| Q1 25 | -5.0% | 14.5% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | -9.0% | 15.1% | ||
| Q1 24 | — | 13.6% |
净利率HCMPRTH
| Q4 25 | 0.7% | 3.6% | ||
| Q3 25 | — | 11.4% | ||
| Q2 25 | 163.8% | 4.5% | ||
| Q1 25 | 3.7% | 3.7% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.7% | ||
| Q2 24 | 8.4% | 0.5% | ||
| Q1 24 | — | 2.5% |
每股收益（稀释后）HCMPRTH
| Q4 25 | $0.00 | $0.10 | ||
| Q3 25 | — | $0.34 | ||
| Q2 25 | $0.52 | $0.14 | ||
| Q1 25 | $0.01 | $0.10 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | $0.03 | $-0.23 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $77.2M |
| 总债务越低越好 | $93.2M | $1.0B |
| 股东权益账面价值 | $1.2B | $-100.4M |
| 总资产 | $1.8B | $2.4B |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资HCMPRTH
| Q4 25 | $1.4B | $77.2M | ||
| Q3 25 | — | $57.0M | ||
| Q2 25 | $1.4B | $50.6M | ||
| Q1 25 | $836.1M | $47.6M | ||
| Q4 24 | — | $58.6M | ||
| Q3 24 | — | $41.1M | ||
| Q2 24 | $802.5M | $34.6M | ||
| Q1 24 | — | $34.3M |
总债务HCMPRTH
| Q4 25 | $93.2M | $1.0B | ||
| Q3 25 | — | $997.5M | ||
| Q2 25 | $93.4M | $917.0M | ||
| Q1 25 | $82.8M | $918.9M | ||
| Q4 24 | — | $920.9M | ||
| Q3 24 | — | $808.1M | ||
| Q2 24 | $82.1M | $809.0M | ||
| Q1 24 | — | $631.4M |
股东权益HCMPRTH
| Q4 25 | $1.2B | $-100.4M | ||
| Q3 25 | — | $-110.3M | ||
| Q2 25 | $1.2B | $-146.1M | ||
| Q1 25 | $759.9M | $-158.3M | ||
| Q4 24 | — | $-166.8M | ||
| Q3 24 | — | $-165.8M | ||
| Q2 24 | $740.1M | $-172.1M | ||
| Q1 24 | — | $-159.9M |
总资产HCMPRTH
| Q4 25 | $1.8B | $2.4B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $1.8B | $2.0B | ||
| Q1 25 | $1.3B | $1.9B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | $1.3B | $1.7B | ||
| Q1 24 | — | $1.6B |
负债/权益比HCMPRTH
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $36.8M |
| 自由现金流经营现金流 - 资本支出 | $3.4M | $30.9M |
| 自由现金流率自由现金流/营收 | 1.2% | 12.5% |
| 资本支出强度资本支出/营收 | 1.8% | 2.4% |
| 现金转化率经营现金流/净利润 | 4.21× | 4.12× |
| 过去12个月自由现金流最近4个季度 | $-96.2M | $75.1M |
8季度趋势，按日历期对齐
经营现金流HCMPRTH
| Q4 25 | $8.2M | $36.8M | ||
| Q3 25 | — | $36.1M | ||
| Q2 25 | $-72.9M | $17.1M | ||
| Q1 25 | $40.3M | $10.0M | ||
| Q4 24 | — | $23.8M | ||
| Q3 24 | — | $19.8M | ||
| Q2 24 | $-39.8M | $28.7M | ||
| Q1 24 | — | $13.3M |
自由现金流HCMPRTH
| Q4 25 | $3.4M | $30.9M | ||
| Q3 25 | — | $30.1M | ||
| Q2 25 | $-82.2M | $9.2M | ||
| Q1 25 | $32.5M | $4.9M | ||
| Q4 24 | — | $19.1M | ||
| Q3 24 | — | $14.5M | ||
| Q2 24 | $-49.9M | $23.6M | ||
| Q1 24 | — | $6.7M |
自由现金流率HCMPRTH
| Q4 25 | 1.2% | 12.5% | ||
| Q3 25 | — | 12.5% | ||
| Q2 25 | -29.6% | 3.8% | ||
| Q1 25 | 10.0% | 2.2% | ||
| Q4 24 | — | 8.4% | ||
| Q3 24 | — | 6.4% | ||
| Q2 24 | -16.3% | 10.7% | ||
| Q1 24 | — | 3.3% |
资本支出强度HCMPRTH
| Q4 25 | 1.8% | 2.4% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | 3.3% | 3.3% | ||
| Q1 25 | 2.4% | 2.3% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | 3.3% | 2.3% | ||
| Q1 24 | — | 3.2% |
现金转化率HCMPRTH
| Q4 25 | 4.21× | 4.12× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | -0.16× | 1.57× | ||
| Q1 25 | 3.38× | 1.20× | ||
| Q4 24 | — | 3.29× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | -1.54× | 28.87× | ||
| Q1 24 | — | 2.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
